Ronald D. Brown

EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of <i>BRAF</i> -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib

Ryan B. Corcoran, Hiromichi Ebi, Alexa B. Turke et al. · Cancer Discovery · 2012 · 1K citations · Full text

Medicine, Oncology, Pharmacology +17

Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models

Ryan B. Corcoran, Katherine A. Cheng, Aaron N. Hata et al. · Cancer Cell · 2012 · 379 citations · Full text

Medicine, Cancer Biology, Oncology +17

TORC1 Suppression Predicts Responsiveness to RAF and MEK Inhibition in <i>BRAF-</i> Mutant Melanoma

Ryan B. Corcoran, S. Michael Rothenberg, Aaron N. Hata et al. · Science Translational Medicine · 2013 · 138 citations

Medicine, Cancer Biology, Oncology +13

Single Dose Captopril as a Diagnostic Test for Primary Aldosteronism*

Daniel F. Lyons, David C. Kem, Ronald D. Brown et al. · The Journal of Clinical Endocrinology & Metabolism · 1983 · 131 citations

Medicine, Endocrinology, Pharmacology +11

A new interstellar molecule: triearbon monoxide

H. E. Matthews, William M. Irvine, Per Friberg et al. · Nature · 1984 · 125 citations

Natural Sciences, Astronomy, Chemistry +11